OTC Oral Care Rinse Recalled Due to Microbial Contamination
StellaLife VEGA Oral Care Peppermint rinse is recalled nationwide due to microbial contamination with Terribacillus species. The affected product was distributed to 60 physician offices.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses, hospitalizations, or injuries. Terribacillus species is not listed among high-risk pathogens, making this a low-risk contamination scenario consistent with precautionary recalls.
Plain-English summary
StellaLife VEGA Oral Care Peppermint, a 16 fl oz (473 ml) oral rinse distributed by StellaLife, is being recalled by Homeocare Laboratories, Inc.
The recall was initiated due to the presence of Terribacillus species organism in the product, representing microbial contamination of a non-sterile product.
The affected product carries Lot #2550 with an expiration date of 02-28-2026 (NDC 69685-143-16). A total of 31,110 units were distributed nationwide to 60 physician offices. No illnesses or injuries have been reported in connection with this product.
The recalled product
- Product
- STELLALIFE VEGA ORAL CARE PEPPERMINT (AZADIRACHTA INDICA, CALENDULA, ECHINACEA PURPUREA, PLANTAGO MAJOR)
- Brand
- STELLALIFE VEGA ORAL CARE PEPPERMINT
- Manufacturer
- Homeocare Laboratories, Inc.
- Category
- Drug — Oral Rinse
- Hazard
- microbial-contamination
- terribacillus
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 2550
- exp. date 02-28-2026
UPCs (1)
- 0867575000404
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27